Skip to main content
logo
SUSMED,Inc. (TYO:4263)
Japan flag Japan · Delayed Price · Currency is JPY
704.00
-6.00 (-0.85%)
Aug 6, 2026, 11:26 AM JST

SUSMED,Inc. Financials Overview

Millions JPY. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
274462342530316115
Revenue Growth
-39.51%35.09%-35.47%67.72%174.78%238.24%
Gross Profit
259450330522305106
Operating Income
-498-300-365-48-230-333
Net Income
-485-298-357-50-233-277
Earnings Per Share
-28.81-17.75-21.39-3.05-15.87-21.65
EPS Growth
------

Revenue by Segment
Fiscal YearFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '24 Jun '23 Jun '22 Jun '21 Jun '20
Digital Therapeutics Product
200400200--
Digital Therapeutics Platform
142.58130.65116.87115.4934.89

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Cash (Debt)
3,9584,3984,8465,0484,9041,626
Net Cash Growth
-12.86%-9.25%-4.00%2.94%201.60%344.26%
Net Cash Per Share
235.09261.90290.30307.76333.99127.09
Cash & Investments
3,9584,3984,8465,0484,9041,626

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
--432-230100-165-
Capital Expenditures
--4-3-6-12-
Free Cash Flow
--436-23394-177-
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
94.53%97.40%96.49%98.49%96.52%92.17%
Operating Margin
-181.75%-64.94%-106.73%-9.06%-72.78%-289.56%
Pretax Margin
-175.91%-64.29%-104.09%-9.25%-73.73%-240.87%
Profit Margin
-177.01%-64.50%-104.39%-9.43%-73.73%-240.87%
FCF Margin
--94.37%-68.13%17.74%-56.01%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
P/FCF Ratio
---314.33--
PS Ratio
43.5722.2429.3755.7546.54-